Overview

A Study to Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure how much of the study drug gets into the blood- stream and how long it takes the body to get rid of it when given as a single dose. Information about any side effects that may occur will also be collected.
Phase:
Phase 1
Details
Lead Sponsor:
BioMarin Pharmaceutical